Australia Approves Co-Diagnostics' Covid-19 Test; Stock Falls On Profit-Taking
CytoDyn Scores Safety Thumbs Up For Late-Stage Covid-19 Trial
DBV craters on FDA’s peanut allergy immunotherapy rejection
National Cancer Institute designates Penn’s Abramson Cancer Center as ‘exceptional’
Regeneron: Covid-19 Antibody Combo Prevents & Treats Disease In Animals
Abiomed’s Impella Scores Emergency FDA Nod For Covid-19 Patients
FDA Expands List Of Dangerous Hand Sanitizers To Over 100
Rival drugmakers launch joint trial of medicines for COVID-19
Eli Lilly Kicks Off Covid-19 Antibody Trial In Nursing Home Residents
Seven plucky diagnostics companies win a $249M round of contracts after surviving NIH's Covid-19 'Shark Tank' competition
Lockdowns Imposed In Melbourne, Manila As Global COVID-19 Total Tops 18 Million: Live Updates
CRISPR Startups Give Genome Editing Several New Twists
Preparing for an influx of cell and gene therapy approvals
Immunic Spikes 35% In Pre-Market On Positive Multiple Sclerosis Data
Immunic Spikes 24% In Pre-Market On Positive Multiple Sclerosis Data
Incyte, MorphoSys Win FDA Nod For ‘Key Revenue Driver’ Tafasitamab
Red Flags Soar As Big Pharma Will Be Exempt from COVID-19 Vaccine Liability Claims
Oppenheimer: These 3 "Strong Buy" Stocks Have Over 50% Upside Potential
Inovio Pharmaceuticals: COVID-19 Vaccine Not the Only Path to Success
Covid-19 roundup: Roger Perlmutter hustles up human vaccine trials as Merck looks to catch up on Covid-19; China hacked Moderna, per official
Covid-19 roundup: China hacked Moderna, per official; Merck prepares to put vaccines into clinic
Covid-19 roundup: Merck prepares to put vaccines into the clinic; Remdesivir keeps Gilead sales afloat
'Partial' Lockdowns Expand In Europe, New COVID-19 Cases Climb In China, Hong Kong: Live Updates
Covid-19 roundup: Despite Q2 sales setback, Gilead revises 2020 sales projection upward thanks to remdesivir
Study puts Jardiance in hot pursuit of AZ’s Farxiga in heart failure
Pooling strategy in the wake of the COVID-19 pandemic: A solution for mass population screening of SARS-CoV-2
Peering into the secrets of phages to see how they kill bacterial superbugs
AstraZeneca beats expectations in Q2, while GSK struggles during pandemic
Johnson & Johnson Starts First Human Trials For Its Covid-19 Candidate
BMS ‘bet’ with Celgene shareholders in balance after CAR-T refile